Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure
Mary Ann Rose(Harvard University), Jay R. Harris(Harvard University), I. Craig Henderson(Harvard University), Steven E. Come, Rebecca Gelman(Dana-Farber Cancer Institute), Stacey M. Gore, John Boyages(Australian Cancer Research Foundation), C. Norman Coleman(Harvard University), Abram Recht(Harvard University), Stuart J. Schnitt(Brigham and Women's Hospital), James L. Connolly(Beth Israel Deaconess Medical Center), Barbara Silver(Brigham and Women's Hospital)
International Journal of Radiation Oncology*Biology*Physics
October 1, 1989
Cited by 74
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Molecular characterization of the tumor microenvironment in breast cancer
|Cancer Cell|2004|1.3k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|988